Conclusion For elderly patients with advanced non-small cell lung cancer and COPD, the use of erlotinib might achieve better security and effectiveness.
2
结论厄洛替尼联合全脑放疗对非小细胞肺癌脑转移灶的疗效高于单纯全脑放疗，且毒副反应可以耐受。
Conclusion the effect of the concomitant of erlotinib and WBRT in patients of NSCLC with brain metastases is better than WBRT alone, and the concomitant therapy is well tolerated.
3
评价单药厄洛替尼治疗晚期非小细胞肺癌合并COPD患者的疗效和安全性。
To evaluate the clinical efficacy and the security of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer and COPD.
点击反馈